Novo Nordisk

News

After missing out on CEO job, Novo's US head quits

The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.

News

Novo completes major filings for blockbuster hope semaglutid...

Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.

News

Patient death raises concerns over Roche haemophilia drug

Concerns following event on HAVEN1 trial.

News

Sanofi diabetes combo approved in EU

Drug will compete against Novo Nordisk's Xultophy.

News

Pfizer, Novo invest in Swedish patient stratification startu...

Funds will go towards development of AMRA's body composition profiling tool AMRA Profiler.

Views & Analysis

Digital health round-up – health innovations shine at CES 20...

A round-up of this week’s top digital healthcare news. Marco Ricci reports.

After missing out on CEO job, Novo's US head quits

Novo completes major filings for blockbuster hope semaglutid...

Patient death raises concerns over Roche haemophilia drug

Sanofi diabetes combo approved in EU

Pfizer, Novo invest in Swedish patient stratification startu...

Digital health round-up – health innovations shine at CES 20...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Novo Nordisk

Editor's Picks